Coherus BioSciences Inc. (CHRS)

17.20
NASDAQ : Health Technology
Prev Close 16.30
Day Low/High 15.95 / 17.45
52 Wk Low/High 8.05 / 17.80
Avg Volume 675.50K
Exchange NASDAQ
Shares Outstanding 65.33M
Market Cap 1.06B
EPS -4.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Sector Steps Up to Provide Some Strong Action for Traders

Biotech Sector Steps Up to Provide Some Strong Action for Traders

The S&P 500 has shown the same pattern for three consecutive days.

A Weak Close Is Going to Have a Significant Impact on Sentiment

A Weak Close Is Going to Have a Significant Impact on Sentiment

It is important for the bulls that the indices close near the highs of the day.

Selling Weak Stocks is Just a Form of Insurance

Selling Weak Stocks is Just a Form of Insurance

Defending gains is important as there is little to buy in the market at the moment

Focused on Individual Stocks

Focused on Individual Stocks

Will we see some consolidation and pullbacks as the recent strength is digested?

Noteworthy Wednesday Option Activity: CHRS, BHGE, BURL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Coherus BioSciences Inc , where a total volume of 3,783 contracts has been traded thus far today, a contract volume which is representative of approximately 378,300 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 49.9% of CHRS's average daily trading volume over the past month, of 757,470 shares.

Interesting CHRS Put And Call Options For March 16th

Interesting CHRS Put And Call Options For March 16th

Investors in Coherus BioSciences Inc saw new options become available this week, for the March 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CHRS options chain for the new March 16th contracts and identified one put and one call contract of particular interest.

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Even with Monday's sharp reversal, Jim Cramer says he still likes this market.

First Week of August 2018 Options Trading For Coherus BioSciences (CHRS)

First Week of August 2018 Options Trading For Coherus BioSciences (CHRS)

Investors in Coherus BioSciences Inc saw new options begin trading this week, for the August 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Coherus BioSciences is Now Oversold (CHRS)

Coherus BioSciences is Now Oversold (CHRS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of May 2018 Options Trading For Coherus BioSciences (CHRS)

First Week of May 2018 Options Trading For Coherus BioSciences (CHRS)

Investors in Coherus BioSciences Inc saw new options become available this week, for the May 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Coherus BioSciences Provides Update On '619 IPR Institution Decision

Coherus BioSciences Provides Update On '619 IPR Institution Decision

Patent Trial and Appeal Board Denies Institution

Commit To Purchase Coherus BioSciences At $10, Earn 12.4% Annualized Using Options

Commit To Purchase Coherus BioSciences At $10, Earn 12.4% Annualized Using Options

Investors eyeing a purchase of Coherus BioSciences Inc stock, but cautious about paying the going market price of $13.28/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2018 put at the $10 strike, which has a bid at the time of this writing of 60 cents.

Coherus Secures Private Placement From Temasek

Coherus Secures Private Placement From Temasek

First tranche of $75 million secured

Coherus BioSciences Enters Oversold Territory (CHRS)

Coherus BioSciences Enters Oversold Territory (CHRS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D- (Sell)